Alireza Labani‐Motlagh

1.0k total citations · 1 hit paper
7 papers, 709 citations indexed

About

Alireza Labani‐Motlagh is a scholar working on Immunology, Molecular Biology and Genetics. According to data from OpenAlex, Alireza Labani‐Motlagh has authored 7 papers receiving a total of 709 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Immunology, 3 papers in Molecular Biology and 2 papers in Genetics. Recurrent topics in Alireza Labani‐Motlagh's work include Immune Cell Function and Interaction (3 papers), Virus-based gene therapy research (2 papers) and Extracellular vesicles in disease (2 papers). Alireza Labani‐Motlagh is often cited by papers focused on Immune Cell Function and Interaction (3 papers), Virus-based gene therapy research (2 papers) and Extracellular vesicles in disease (2 papers). Alireza Labani‐Motlagh collaborates with scholars based in Sweden, United States and Iran. Alireza Labani‐Motlagh's co-authors include Angelica Loskog, Jessica Wenthe, Emma Eriksson, Ivan Nagaev, Vladimir Baranov, Eva Lundin, Ulrika Ottander, Olga Nagaeva, Eva Dehlin and Lucia Mincheva‐Nilsson and has published in prestigious journals such as Frontiers in Immunology, Cancer Immunology Immunotherapy and Tumor Biology.

In The Last Decade

Alireza Labani‐Motlagh

7 papers receiving 699 citations

Hit Papers

The Tumor Microenvironment: A Milieu Hindering and Obstru... 2020 2026 2022 2024 2020 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alireza Labani‐Motlagh Sweden 6 363 352 282 125 94 7 709
Zhenqing Feng China 14 204 0.6× 368 1.0× 261 0.9× 150 1.2× 72 0.8× 26 674
Huajun Jin China 15 238 0.7× 414 1.2× 321 1.1× 121 1.0× 93 1.0× 27 731
Xuexiang Du United States 10 504 1.4× 586 1.7× 204 0.7× 74 0.6× 61 0.6× 21 856
Marleen Ansems Netherlands 18 365 1.0× 210 0.6× 264 0.9× 115 0.9× 65 0.7× 38 835
Hualing Zhang China 5 343 0.9× 360 1.0× 254 0.9× 125 1.0× 98 1.0× 8 708
Jessica Fioravanti Spain 15 559 1.5× 400 1.1× 209 0.7× 76 0.6× 58 0.6× 22 998
Sarah Maenhout Belgium 13 552 1.5× 425 1.2× 395 1.4× 89 0.7× 57 0.6× 13 889
Jan Martínek United States 7 492 1.4× 397 1.1× 244 0.9× 75 0.6× 77 0.8× 14 924
Dahlia M. Besmer United States 11 213 0.6× 317 0.9× 397 1.4× 111 0.9× 37 0.4× 14 679
Maxime Dhainaut United States 7 436 1.2× 335 1.0× 240 0.9× 54 0.4× 56 0.6× 12 707

Countries citing papers authored by Alireza Labani‐Motlagh

Since Specialization
Citations

This map shows the geographic impact of Alireza Labani‐Motlagh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alireza Labani‐Motlagh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alireza Labani‐Motlagh more than expected).

Fields of papers citing papers by Alireza Labani‐Motlagh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alireza Labani‐Motlagh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alireza Labani‐Motlagh. The network helps show where Alireza Labani‐Motlagh may publish in the future.

Co-authorship network of co-authors of Alireza Labani‐Motlagh

This figure shows the co-authorship network connecting the top 25 collaborators of Alireza Labani‐Motlagh. A scholar is included among the top collaborators of Alireza Labani‐Motlagh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alireza Labani‐Motlagh. Alireza Labani‐Motlagh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Labani‐Motlagh, Alireza, José Alejandro Bohórquez, Sahil D. Patel, et al.. (2024). Bacteriophage therapy for the treatment of Mycobacterium tuberculosis infections in humanized mice. Communications Biology. 7(1). 294–294. 20 indexed citations
2.
Srivastava, Rashmi, Alireza Labani‐Motlagh, Apeng Chen, et al.. (2023). Development of a human glioblastoma model using humanized DRAG mice for immunotherapy. PubMed. 6(4). 253–264. 4 indexed citations
3.
Azizi, Mahdieh, et al.. (2022). The role of NK and NKT cells in the pathogenesis and improvement of multiple sclerosis following disease‐modifying therapies. Health Science Reports. 5(1). e489–e489. 11 indexed citations
4.
Wenthe, Jessica, Alireza Labani‐Motlagh, Gunilla Enblad, et al.. (2021). Boosting CAR T-cell responses in lymphoma by simultaneous targeting of CD40/4-1BB using oncolytic viral gene therapy. Cancer Immunology Immunotherapy. 70(10). 2851–2865. 40 indexed citations
5.
Labani‐Motlagh, Alireza, et al.. (2021). Systemic immunity upon local oncolytic virotherapy armed with immunostimulatory genes may be supported by tumor-derived exosomes. Molecular Therapy — Oncolytics. 20. 508–518. 34 indexed citations
6.
Labani‐Motlagh, Alireza, et al.. (2020). The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses. Frontiers in Immunology. 11. 940–940. 525 indexed citations breakdown →
7.
Labani‐Motlagh, Alireza, Ulrika Ottander, Eva Lundin, et al.. (2015). Differential expression of ligands for NKG2D and DNAM-1 receptors by epithelial ovarian cancer-derived exosomes and its influence on NK cell cytotoxicity. Tumor Biology. 37(4). 5455–5466. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026